Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the region as the pituitary enhancer of X-linked acrogigantism

Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg J-H, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy P, Ferrante E, Strebkova N, Mazerkina N, Zatelli M, Lodish M, Horvath A, de Alexandre R, Manning A, Levy I, Keil M, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves L, Jamar M, Bours V, Wu T, Choong C, Bertherat J, Chanson P, Kamenický P, Farrell W, Barlier A, Quezado M, Bjelobaba I, Stojilkovic S, Wess J, Costanzi S, Liu P, Lupski J, Beckers A, Stratakis C (2014) Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371(25):2363–2374

CAS  PubMed  PubMed Central  Google Scholar 

Daly AF, Beckers A (2024) The genetic pathophysiology and clinical management of the tadopathy, X-Linked acrogigantism. Endocr Rev 45(5):737–754

PubMed  Google Scholar 

Franke M, Daly AF, Palmeira L, Tirosh A, Stigliano A, Trifan E, Faucz FR, Abboud D, Petrossians P, Tena JJ, Vitali E, Lania AG, Gómez-Skarmeta JL, Beckers A, Stratakis CA, Trivellin G (2022) Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. Am J Hum Genet 109(4):553–570

CAS  PubMed  PubMed Central  Google Scholar 

Iacovazzo D, Caswell R, Bunce B, Jose S, Yuan B, Hernandez-Ramirez LC, Kapur S, Caimari F, Evanson J, Ferrau F, Dang MN, Gabrovska P, Larkin SJ, Ansorge O, Rodd C, Vance ML, Ramirez-Renteria C, Mercado M, Goldstone AP, Buchfelder M, Burren CP, Gurlek A, Dutta P, Choong CS, Cheetham T, Trivellin G, Stratakis CA, Lopes MB, Grossman AB, Trouillas J, Lupski JR, Ellard S, Sampson JR, Roncaroli F, Korbonits M (2016) Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study. Acta Neuropathol Commun 4(1):56

PubMed  PubMed Central  Google Scholar 

da Costa-Nunes JA, Noordermeer D, TADs (2023) Dynamic structures to create stable regulatory functions. Curr Opin Struct Biol 81:102622

PubMed  Google Scholar 

Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevigné A, Ectors F, Plenevaux A, Pirotte B, Beckers A, Hanson J (2020) GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G(s) and G(q/11). Nat Commun 11(1):4752

CAS  PubMed  PubMed Central  Google Scholar 

Daly AF, Dunnington LA, Rodriguez-Buritica DF, Spiegel E, Brancati F, Mantovani G, Rawal VM, Faucz FR, Hijazi H, Caberg JH, Nardone AM, Bengala M, Fortugno P, Del Sindaco G, Ragonese M, Gould H, Cannavò S, Pétrossians P, Lania A, Lupski JR, Beckers A, Stratakis CA, Levy B, Trivellin G, Franke M (2024) Chromatin conformation capture in the clinic: 4 C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus. Genome Med 16(1):112

CAS  PubMed  PubMed Central  Google Scholar 

De Sousa SMC, Lenders NF, Lamb LS, Inder WJ, McCormack A (2023) Pituitary tumours: molecular and genetic aspects. J Endocrinol.;257(3)

Newman S, Hermetz KE, Weckselblatt B, Rudd MK (2015) Next-generation sequencing of duplication CNVs reveals that most are tandem and some create fusion genes at breakpoints. Am J Hum Genet 96(2):208–220

CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif